Healthcare3 min reading time
Rivercell raises $25M to build an AI model of how cells respond to drugs
The Next Web
Read the full article
Rivercell, a Paris-based startup, raised $25M to develop an AI model simulating how human cells respond to drugs and genetic changes by generating its own experimental data. The company aims to create a comprehensive 'world model' of the cell to improve medical understanding and reduce physical lab experiments.
